AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.35
-0.53 (-9.01%)
At close: Jul 15, 2025, 4:00 PM
5.35
0.00 (0.00%)
After-hours: Jul 15, 2025, 4:37 PM EDT
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $142.12 million as of July 15, 2025. Its market cap has decreased by -31.11% in one year.
Market Cap
142.12M
Enterprise Value
163.82M
1-Year Change
-31.11%
Ranking
Category
Stock Price
$5.35
Market Cap Chart
Since March 29, 2012, AVITA Medical's market cap has increased from $59.55M to $142.12M, an increase of 138.67%. That is a compound annual growth rate of 6.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 156.19M | -53.81% |
| Dec 31, 2024 | 338.19M | -4.00% |
| Dec 29, 2023 | 352.28M | 111.74% |
| Dec 30, 2022 | 166.38M | -44.28% |
| Dec 31, 2021 | 298.61M | -25.68% |
| Dec 31, 2020 | 401.79M | -58.30% |
| Dec 31, 2019 | Pro | Pro |
| Dec 31, 2018 | Pro | Pro |
| Dec 29, 2017 | Pro | Pro |
| Dec 30, 2016 | Pro | Pro |
| Dec 31, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |